Maxygen: Bayer $30 Million Payment Likely In 2012
Apsara Biotechnology Research
•
Wed, May 2, 2012
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
Maxygen: A Biotech Play With Low Downside - Part 1Apsara Biotechnology Research • Thu, Mar 1, 2012
-
Quick Take: Maxygen, Inc.MagicDiligence • Fri, Feb 6, 2009
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
2012's Low P/E StocksValue Research • Tue, Jan 10, 2012 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Maxygen, Inc. Q4 2008 Earnings Call TranscriptTue, Feb 10, 2009
-
Maxygen Inc Q3 2008 Earnings Call TranscriptTue, Nov 4, 2008
-
Maxygen, Inc. Q2 2008 Earnings Conference Call TranscriptThu, Jul 31, 2008
-
Maxygen, Inc., Q1 2008 Earnings Call TranscriptTue, May 6, 2008
-
Maxygen Inc. Q4 2007 Earnings Call TranscriptTue, Feb 12, 2008
-
Business Wire (Jun 3, 2013)
-
Business Wire (May 3, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Jan 29, 2013)
-
Business Wire (Nov 6, 2012)
-
at MarketWatch.com (Aug 8, 2012)
-
Business Wire (Aug 7, 2012)
-
Business Wire (May 14, 2012)
-
Business Wire (May 7, 2012)
-
Business Wire (Jan 10, 2012)
-
at MarketWatch.com (Mar 17, 2011)
-
at MarketWatch.com (Dec 15, 2010)
-
at MarketWatch.com (Dec 15, 2010)
-
at MarketWatch.com (Nov 23, 2010)
MAXY vs. ETF Alternatives
Company Description
Currently, there's no company description for MAXY.
